article thumbnail

Disappointing data lead Pfizer to drop heart drug acquired as part of $11B deal

MedCity News

billion acquisition of Array Biopharma in 2019. Pfizer is stopping work on a drug for a rare heart disease after an interim look at Phase 3 data indicated that the study was unlikely to succeed. The small molecule came to Pfizer’s drug pipeline as part of the $11.4

Biopharma 312
article thumbnail

Lung cancer deaths decline but.

World of DTC Marketing

The mortality rate from lung cancer has dropped in recent decades—by 56% in men from 1990 to 2019 and by 32% in women from 2002 to 2019. But it’s still the leading cause of cancer deaths. The mortality rate from lung cancer has dropped in recent decades—by 56% in men from 1990 to 2019 and by 32% in women from 2002 to 2019.

Medicine 271
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Our Best of 2018- to Fuel Your Best 2019

Integrity Solutions

Here is some of our ‘Best of 2018’ content that can help fuel thoughts, discussions and strategies to make 2019 your best year yet. We look forward to serving the world with integrity even more in 2019. To your success… The post Our Best of 2018- to Fuel Your Best 2019 appeared first on Integrity Solutions.

article thumbnail

Gilead’s CMO to depart next year

PharmaVoice

Merdad Parsey joined Gilead as its chief medical officer in 2019 and has helped lead the company’s expansion into oncology, with mixed success.

Leads 148
article thumbnail

Forrester Research Report: How Sales and Marketing Intelligence Drive Improved Business Outcomes

In 2019, DiscoverOrg commissioned Forrester Consulting to evaluate sales and marketing intelligence practices in the B2B space. Those implementing a B2B sales and marketing intelligence solution reported that they have realized 35% more leads in their pipeline and 45% higher-quality leads leading to higher revenue and growth.

article thumbnail

Medical Devices Are Evolving Toward Specialized Solutions

MedCity News

It is a minimally invasive treatment that has shown tremendous promise in addressing vascular calcification, which increases the risk of heart attacks, strokes, or blood clots, and can lead to limb amputations. In February of 2019, Johnson & Johnson acquired Auris Health and its FDA-cleared Monarch platform for $5.75

article thumbnail

A perfect storm for biotech stocks

World of DTC Marketing

According to STAT News “after a double-digit decline in 2021, the sector has fallen another 20% in the new year, erasing billions in value and leading even the most seasoned investors to question whether biotech has further to fall. That’s significantly down from 2019, with 70 deals worth $261 billion.